Michael Certo is an experienced leader in the field of cell and gene therapy, currently serving as Vice President of Regeneron Cell Medicines, where oversight of the research department includes discovery, pre-clinical development, and data sciences for CAR/TCR cell therapies. Previously, Michael held multiple senior roles at 2seventy bio and bluebird bio, focusing on genome editing strategies and research programs in oncology. Academic contributions include a post-doctoral fellowship at Harvard Medical School and a Doctor of Philosophy in Molecular and Cellular Biology from the University of Washington. Michael also has a strong foundation in biology with a Bachelor of Science from Fairfield University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices